A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.
A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).
The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.
A characteristic symptom complex.
The circulation of BLOOD, of both the mother and the FETUS, through the PLACENTA.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
The collecting of fetal blood samples typically via ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION from the umbilical vein.
Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.
The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.
The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.
Specialized arterial vessels in the umbilical cord. They carry waste and deoxygenated blood from the FETUS to the mother via the PLACENTA. In humans, there are usually two umbilical arteries but sometimes one.
A condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.
Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
The circulation of the BLOOD through the LUNGS.
A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more.

Cerebral blood flow during treatment for pulmonary hypertension. (1/91)

AIM: To determine if the haemodynamics of systemic and cerebral circulation are changed during treatment for persistent pulmonary hypertension of the newborn (PPHN). METHODS: Fifteen term newborn piglets with hypoxia induced pulmonary hypertension were randomly assigned either tolazoline infusion (Tz), hyperventilation alkalosis(HAT), and inhaled nitric oxide (iNO). Mean pulmonary arterial pressure (PAP), mean systemic arterial pressure (SAP), and cerebral blood flow volume (CBF) were measured. RESULTS: During hypoxic breathing, PAP increased significantly in all groups. After treatment PAP decreased significantly in all groups, but no significant difference was observed between groups. SAP decreased significantly only in the Tz group, and CBF reduced significantly only in the HAT group. On the other hand, iNO did not change SAP or CBF. CONCLUSION: Inhaled NO might be ideal for the resolution of pulmonary hypertension.  (+info)

Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. (2/91)

BACKGROUND: Inhaled nitric oxide improves gas exchange in neonates, but the efficacy of low-dose inhaled nitric oxide in reducing the need for extracorporeal membrane oxygenation has not been established. METHODS: We conducted a clinical trial to determine whether low-dose inhaled nitric oxide would reduce the use of extracorporeal membrane oxygenation in neonates with pulmonary hypertension who were born after 34 weeks' gestation, were 4 days old or younger, required assisted ventilation, and had hypoxemic respiratory failure as defined by an oxygenation index of 25 or higher. The neonates who received nitric oxide were treated with 20 ppm for a maximum of 24 hours, followed by 5 ppm for no more than 96 hours. The primary end point of the study was the use of extracorporeal membrane oxygenation. RESULTS: Of 248 neonates enrolled, 126 were randomly assigned to the nitric oxide group and 122 to the control group. Extracorporeal membrane oxygenation was used in 78 neonates in the control group (64 percent) and in 48 neonates in the nitric oxide group (38 percent) (P=0.001). The 30-day mortality rate in the two groups was similar (8 percent in the control group and 7 percent in the nitric oxide group). Chronic lung disease developed less often in neonates treated with nitric oxide than in those in the control group (7 percent vs. 20 percent, P=0.02). The efficacy of nitric oxide was independent of the base-line oxygenation index and the primary pulmonary diagnosis. CONCLUSIONS: Inhaled nitric oxide reduces the extent to which extracorporeal membrane oxygenation is needed in neonates with hypoxemic respiratory failure and pulmonary hypertension.  (+info)

Inhaled nitric oxide in the management of persistent pulmonary hypertension of the newborn: a meta-analysis. (3/91)

OBJECTIVES: To evaluate the use of inhaled nitric oxide (NO) in the management of persistent pulmonary hypertension of the newborn. METHODS: Computerized bibliographic search on MEDLINE, CURRENT CONTENTS and LILACS covering the period from January 1990 to March 1998; review of references of all papers found on the subject. Only randomized clinical trials evaluating nitric oxide and conventional treatment were included. OUTCOMES STUDIED: death, requirement for extracorporeal membrane oxygenation (ECMO), systemic oxygenation, complications at the central nervous system and development of chronic pulmonary disease. The methodologic quality of the studies was evaluated by a quality score system, on a scale of 13 points. RESULTS: For infants without congenital diaphragmatic hernia, inhaled NO did not change mortality (typical odds ratio: 1.04; 95% CI: 0.6 to 1.8); the need for ECMO was reduced (relative risk: 0.73; 95% CI: 0.60 to 0.90), and the oxygenation was improved (PaO2 by a mean of 53.3 mm Hg; 95% CI: 44.8 to 61.4; oxygenation index by a mean of -12.2; 95% CI: -14.1 to -9.9). For infants with congenital diaphragmatic hernia, mortality, requirement for ECMO, and oxygenation were not changed. For all infants, central nervous system complications and incidence of chronic pulmonary disease did not change. CONCLUSIONS: Inhaled NO improves oxygenation and reduces requirement for ECMO only in newborns with persistent pulmonary hypertension who do not have diaphragmatic hernia. The risk of complications of the central nervous system and chronic pulmonary disease were not affected by inhaled NO.  (+info)

Extremely thickened media of small pulmonary arteries in fatal pulmonary hypertension with congenital heart disease--a morphometric and clinicopathological study. (4/91)

There are patients with congenital heart disease and fatal pulmonary hypertension in whom the medial hypertrophy of the small pulmonary arteries is quite beyond the extent of ordinary cases of hypertension, a condition described as pulmonary hypertension with extremely thickened media of small pulmonary arteries (PH/ETM). Lungs from 6 infants, all younger than 2 years of age, who had congenital heart disease and fatal pulmonary hypertension, were analyzed by accurately measuring the media using Suwa's method. In PH/ETM, the media of the small pulmonary arteries was shown to be not only unusually thick, but extending toward the periphery, whereas the intimal changes were unexpectedly mild. In the PH/ETM group, the % wall thickness at a diameter of 50 microm (%Tw(50)), determined from regression analysis, was 23.2+/-1.3%, which was significantly higher than in either the control (10.3+/-1.2%) or ventricular septal defect group (18.9+/-1.6%). In persistent pulmonary hypertension of the newborn (PPHN), it was 22.3+/-1.8%, not significantly different from PH/ETM. The striking medial hypertrophy in PH/ETM and PPHN was apparently confined to small pulmonary arteries and in both conditions is likely to be the result of maldevelopment of these arteries. Surgical intervention may trigger a critical elevation of the pulmonary arterial resistance.  (+info)

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. (5/91)

BACKGROUND: Endogenous production of nitric oxide is vital for the decrease in pulmonary vascular resistance that normally occurs after birth. The precursor of nitric oxide is arginine, a urea-cycle intermediate. We hypothesized that low concentrations of arginine would correlate with the presence of persistent pulmonary hypertension in newborns and that the supply of this precursor would be affected by a functional polymorphism (the substitution of asparagine for threonine at position 1405 [T1405N]) in carbamoyl-phosphate synthetase, which controls the rate-limiting step of the urea cycle. METHODS: Plasma concentrations of amino acids and genotypes of the carbamoyl-phosphate synthetase variants were determined in 65 near-term neonates with respiratory distress. Plasma nitric oxide metabolites were measured in a subgroup of 10 patients. The results in infants with pulmonary hypertension, as assessed by echocardiography, were compared with those in infants without pulmonary hypertension. The frequencies of the carbamoyl-phosphate synthetase genotypes in the study population were assessed for Hardy-Weinberg equilibrium. RESULTS: As compared with infants without pulmonary hypertension, infants with pulmonary hypertension had lower mean (+/-SD) plasma concentrations of arginine (20.2+/-8.8 vs. 39.8+/-17.0 micromol per liter, P<0.001) and nitric oxide metabolites (18.8+/-12.7 vs. 47.2+/-11.2 micromol per liter, P=0.05). As compared with the general population, the infants in the study had a significantly skewed distribution of the genotypes for the carbamoyl-phosphate synthetase variants at position 1405 (P<0.005). None of the infants with pulmonary hypertension were homozygous for the T1405N polymorphism. CONCLUSIONS: Infants with persistent pulmonary hypertension have low plasma concentrations of arginine and nitric oxide metabolites. The simultaneous presence of diminished concentrations of precursors and breakdown products suggests that inadequate production of nitric oxide is involved in the pathogenesis of neonatal pulmonary hypertension. Our preliminary observations suggest that the genetically predetermined capacity of the urea cycle--in particular, the efficiency of carbamoyl-phosphate synthetase--may contribute to the availability of precursors for nitric oxide synthesis.  (+info)

Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience. (6/91)

OBJECTIVE: To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis. METHODS: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyperventilation or systemic alkalosis were not attempted. RESULTS: Mean duration of ventilation was 9.9 +/- 14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7 +/- 4.3 cm H(2)O at the referral hospital to 13.2 +/- 2.5 cm H(2)O (p < 0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8 +/- 24.5 to 22.7 +/- 21.4 within 24 hours of INO therapy (p < 0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p < 0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p < 0.01). In the infants treated with GV alone, the MAP dropped from 17.2 +/- 4.3 cm H2O at the referral hospital to 12.6+/-2.4 after GV was started in our unit. CONCLUSIONS: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.  (+info)

Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants. (7/91)

The peptide endothelin-1 (ET-1) plays an unknown role in the pathogenesis and progression of two important neonatal pulmonary disorders, chronic lung disease (CLD) of prematurity and persistent pulmonary hypertension of the newborn (PPHN). Inhaled nitric oxide (INO) is a proven vasodilator therapy in PPHN and is an experimental therapy in CLD. We sought to determine the effects, if any, of the interaction of inhaled INO with ET-1 in these two separate disorders. Infants (n=21) with PPHN (mean gestation age, 39.4 weeks; mean birth weight, 3470 g) were treated with INO. All infants were <72 h of age at baseline. Plasma obtained at baseline and after 24 h of INO therapy was assessed for ET-1. The change in ET-1 levels with INO was inversely correlated with change in arterial partial pressure of O(2) (r=-0.71, P=0.0003). A separate group of 33 patients with CLD (mean gestational age, 27 weeks; mean birth weight, 740 g; mean age, 19 days) had tracheal aspirate levels of ET-1 obtained before, during, and after 7 days' administration of INO. Values were normalized by soluble secretory component of IgA. Tracheal aspirate ET-1 levels were detectable before INO therapy. There was no significant change during or after treatment with INO. There was not a significant correlation between baseline fractional inspired O(2) and ET-1 levels. There was a non-significant trend in the correlation between the change in ET-1 and the change in interleukin-8 levels in tracheal aspirate. This report confirms the presence of ET-1 in tracheal aspirate of premature infants who are developing CLD and reaffirms the presence of ET-1 in plasma of infants with PPHN. Short-term INO therapy was associated with a decrease in plasma ET-1 levels in PPHN, but did not affect tracheal aspirate ET-1 in CLD. Given the vasconstrictive, profibrotic, and proinflammatory properties of ET-1, specific ET-1 receptor antagonists could be considered as candidates for trials as adjunct therapy in either or both of these disorders.  (+info)

Extracorporeal membrane oxygenation for perinatal and pediatric patients. (8/91)

Extracorporeal membrane oxygenation (ECMO) is a technique developed to ensure adequate tissue oxygen delivery in patients suffering cardiac and/or respiratory failure. ECMO can provide this delivery without causing the iatrogenic damage associated with high mechanical ventilation pressures, high fraction of inspired oxygen, or high doses of inotropic medications. Though practitioners use a multitude of other, more "conventional," therapies for neonatal respiratory failure, only ECMO has been proven in a randomized, controlled, clinical trial to improve both mortality and morbidity among neonates. Though a randomized controlled trial of ECMO in the neonate has been published, to date no trial in the pediatric, adult, or cardiac population is complete. The Extracorporeal Life Support Organization registry provides data on the over 20,000 ECMO cases performed to date and serves as a resource to refine this supportive therapy. This support is not without complications, and it should be used in appropriate populations, with specific criteria for initiation.  (+info)

Persistent Fetal Circulation Syndrome (PFCS), also known as Persistent Truncus Arteriosus or Failure of Infant Pulmonary Circulation to Develop, is a rare and complex congenital heart defect. It is a condition where the fetal circulatory patterns persist after birth, preventing the normal transition from fetal to neonatal circulation.

In a healthy newborn, the circulation changes so that oxygenated blood flows to the body through the aorta and deoxygenated blood returns to the lungs through the pulmonary artery. However, in PFCS, the blood bypasses the lungs because of a lack of communication between the systemic and pulmonary circulations. This results in insufficient oxygen supply to the body and cyanosis (bluish discoloration of the skin and mucous membranes).

The main features of PFCS include:

1. Patent Ductus Arteriosus (PDA): A persistent opening between the pulmonary artery and the aorta, which should normally close after birth.
2. Persistent Foramen Ovale (PFO): An opening between the two atria of the heart that should also close after birth.
3. Reversed or absent flow in the ductus arteriosus or ligamentum arteriosum.
4. Intact ventricular septum, meaning there is no hole between the lower chambers (ventricles) of the heart.
5. Underdevelopment or absence of the pulmonary arterial tree and/or decreased pulmonary blood flow.

PFCS can vary in severity, and its diagnosis typically requires a combination of clinical evaluation, imaging studies such as echocardiography, and sometimes cardiac catheterization. Treatment usually involves surgical intervention to establish normal circulation and improve oxygenation. The prognosis depends on the severity of the condition and the timeliness and effectiveness of the treatment.

Maternal-fetal exchange, also known as maternal-fetal transport or placental transfer, refers to the physiological process by which various substances are exchanged between the mother and fetus through the placenta. This exchange includes the transfer of oxygen and nutrients from the mother's bloodstream to the fetal bloodstream, as well as the removal of waste products and carbon dioxide from the fetal bloodstream to the mother's bloodstream.

The process occurs via passive diffusion, facilitated diffusion, and active transport mechanisms across the placental barrier, which is composed of fetal capillary endothelial cells, the extracellular matrix, and the syncytiotrophoblast layer of the placenta. The maternal-fetal exchange is crucial for the growth, development, and survival of the fetus throughout pregnancy.

The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the growing baby through the umbilical cord. It also removes waste products from the baby's blood. The placenta attaches to the wall of the uterus, and the baby's side of the placenta contains many tiny blood vessels that connect to the baby's circulatory system. This allows for the exchange of oxygen, nutrients, and waste between the mother's and baby's blood. After the baby is born, the placenta is usually expelled from the uterus in a process called afterbirth.

A fetus is the developing offspring in a mammal, from the end of the embryonic period (approximately 8 weeks after fertilization in humans) until birth. In humans, the fetal stage of development starts from the eleventh week of pregnancy and continues until childbirth, which is termed as full-term pregnancy at around 37 to 40 weeks of gestation. During this time, the organ systems become fully developed and the body grows in size. The fetus is surrounded by the amniotic fluid within the amniotic sac and is connected to the placenta via the umbilical cord, through which it receives nutrients and oxygen from the mother. Regular prenatal care is essential during this period to monitor the growth and development of the fetus and ensure a healthy pregnancy and delivery.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Placental circulation refers to the specialized circulatory system that develops during pregnancy to allow for the exchange of nutrients, oxygen, and waste products between the mother's blood and the fetal blood in the placenta. The placenta is a highly vascular organ that grows within the uterus and is connected to the developing fetus via the umbilical cord.

In the maternal side of the placenta, the spiral arteries branch into smaller vessels called the intervillous spaces, where they come in close contact with the fetal blood vessels within the villi (finger-like projections) of the placenta. The intervillous spaces are filled with maternal blood that flows around the villi, allowing for the exchange of gases and nutrients between the two circulations.

On the fetal side, the umbilical cord contains two umbilical arteries that carry oxygen-depleted blood from the fetus to the placenta, and one umbilical vein that returns oxygenated blood back to the fetus. The umbilical arteries branch into smaller vessels within the villi, where they exchange gases and nutrients with the maternal blood in the intervillous spaces.

Overall, the placental circulation is a crucial component of fetal development, allowing for the growing fetus to receive the necessary oxygen and nutrients to support its growth and development.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Cordocentesis, also known as percutaneous umbilical blood sampling (PUBS), is a medical procedure in which a small amount of fetal blood is withdrawn from the umbilical cord for diagnostic testing. It is typically performed when there is a concern for fetal anemia, chromosomal abnormalities, or other genetic disorders. The procedure involves inserting a thin needle through the mother's abdomen and uterus to reach the umbilical cord, usually during the second trimester of pregnancy. Cordocentesis carries a small risk of complications, including fetal injury, infection, and premature labor.

Fetal blood refers to the blood circulating in a fetus during pregnancy. It is essential for the growth and development of the fetus, as it carries oxygen and nutrients from the placenta to the developing tissues and organs. Fetal blood also removes waste products, such as carbon dioxide, from the fetal tissues and transports them to the placenta for elimination.

Fetal blood has several unique characteristics that distinguish it from adult blood. For example, fetal hemoglobin (HbF) is the primary type of hemoglobin found in fetal blood, whereas adults primarily have adult hemoglobin (HbA). Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin, which allows it to more efficiently extract oxygen from the maternal blood in the placenta.

Additionally, fetal blood contains a higher proportion of reticulocytes (immature red blood cells) and nucleated red blood cells compared to adult blood. These differences reflect the high turnover rate of red blood cells in the developing fetus and the need for rapid growth and development.

Examination of fetal blood can provide important information about the health and well-being of the fetus during pregnancy. For example, fetal blood sampling (also known as cordocentesis or percutaneous umbilical blood sampling) can be used to diagnose genetic disorders, infections, and other conditions that may affect fetal development. However, this procedure carries risks, including preterm labor, infection, and fetal loss, and is typically only performed when there is a significant risk of fetal compromise or when other diagnostic tests have been inconclusive.

Blood circulation, also known as cardiovascular circulation, refers to the process by which blood is pumped by the heart and circulated throughout the body through a network of blood vessels, including arteries, veins, and capillaries. This process ensures that oxygen and nutrients are delivered to cells and tissues, while waste products and carbon dioxide are removed.

The circulation of blood can be divided into two main parts: the pulmonary circulation and the systemic circulation. The pulmonary circulation involves the movement of blood between the heart and the lungs, where it picks up oxygen and releases carbon dioxide. The systemic circulation refers to the movement of blood between the heart and the rest of the body, delivering oxygen and nutrients to cells and tissues while picking up waste products for removal.

The heart plays a central role in blood circulation, acting as a pump that contracts and relaxes to move blood through the body. The contraction of the heart's left ventricle pushes oxygenated blood into the aorta, which then branches off into smaller arteries that carry blood throughout the body. The blood then flows through capillaries, where it exchanges oxygen and nutrients for waste products and carbon dioxide with surrounding cells and tissues. The deoxygenated blood is then collected in veins, which merge together to form larger vessels that eventually return the blood back to the heart's right atrium. From there, the blood is pumped into the lungs to pick up oxygen and release carbon dioxide, completing the cycle of blood circulation.

Gestational age is the length of time that has passed since the first day of the last menstrual period (LMP) in pregnant women. It is the standard unit used to estimate the age of a pregnancy and is typically expressed in weeks. This measure is used because the exact date of conception is often not known, but the start of the last menstrual period is usually easier to recall.

It's important to note that since ovulation typically occurs around two weeks after the start of the LMP, gestational age is approximately two weeks longer than fetal age, which is the actual time elapsed since conception. Medical professionals use both gestational and fetal age to track the development and growth of the fetus during pregnancy.

The umbilical arteries are a pair of vessels that develop within the umbilical cord during fetal development. They carry oxygenated and nutrient-rich blood from the mother to the developing fetus through the placenta. These arteries arise from the internal iliac arteries in the fetus and pass through the umbilical cord to connect with the two umbilical veins within the placenta. After birth, the umbilical arteries become ligaments (the medial umbilical ligaments) that run along the inner abdominal wall.

Meconium Aspiration Syndrome (MAS) is a medical condition that occurs in newborns when meconium, which is the first stool of an infant, is present in the amniotic fluid and is breathed into the lungs around the time of delivery. This can cause respiratory distress, pneumonia, and in severe cases, persistent pulmonary hypertension and death.

The meconium can be inhaled into the lungs before, during, or after birth, and it can block the airways, causing a lack of oxygen to the lungs and other organs. This can lead to several complications such as infection, inflammation, and damage to the lung tissue.

MAS is more likely to occur in babies who are born past their due date or those who experience fetal distress during labor and delivery. Treatment for MAS may include oxygen therapy, suctioning of the airways, antibiotics, and in severe cases, mechanical ventilation.

Placental insufficiency is a condition in which the placenta does not provide adequate nutrients and oxygen to the developing fetus. This can occur due to various reasons, such as poor placental development, damage to the placenta, or problems with the blood flow to the placenta. As a result, the fetus may receive less oxygen and nutrients than it needs for proper growth and development, which can lead to a range of complications, including low birth weight, preterm birth, and developmental delays.

The medical definition of placental insufficiency is: "a condition in which the placenta fails to provide adequate support to the developing fetus, resulting in impaired fetal growth and development." This condition can be diagnosed through various tests, such as ultrasound, fetal monitoring, and blood tests, and may require close monitoring and management throughout pregnancy to ensure the best possible outcomes for both the mother and the baby.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Pulmonary hypertension is a medical condition characterized by increased blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the right side of the heart to the lungs. This results in higher than normal pressures in the pulmonary circulation and can lead to various symptoms and complications.

Pulmonary hypertension is typically defined as a mean pulmonary artery pressure (mPAP) greater than or equal to 25 mmHg at rest, as measured by right heart catheterization. The World Health Organization (WHO) classifies pulmonary hypertension into five groups based on the underlying cause:

1. Pulmonary arterial hypertension (PAH): This group includes idiopathic PAH, heritable PAH, drug-induced PAH, and associated PAH due to conditions such as connective tissue diseases, HIV infection, portal hypertension, congenital heart disease, and schistosomiasis.
2. Pulmonary hypertension due to left heart disease: This group includes conditions that cause elevated left atrial pressure, such as left ventricular systolic or diastolic dysfunction, valvular heart disease, and congenital cardiovascular shunts.
3. Pulmonary hypertension due to lung diseases and/or hypoxia: This group includes chronic obstructive pulmonary disease (COPD), interstitial lung disease, sleep-disordered breathing, alveolar hypoventilation disorders, and high altitude exposure.
4. Chronic thromboembolic pulmonary hypertension (CTEPH): This group includes persistent obstruction of the pulmonary arteries due to organized thrombi or emboli.
5. Pulmonary hypertension with unclear and/or multifactorial mechanisms: This group includes hematologic disorders, systemic disorders, metabolic disorders, and other conditions that can cause pulmonary hypertension but do not fit into the previous groups.

Symptoms of pulmonary hypertension may include shortness of breath, fatigue, chest pain, lightheadedness, and syncope (fainting). Diagnosis typically involves a combination of medical history, physical examination, imaging studies, and invasive testing such as right heart catheterization. Treatment depends on the underlying cause but may include medications, oxygen therapy, pulmonary rehabilitation, and, in some cases, surgical intervention.

Pulmonary circulation refers to the process of blood flow through the lungs, where blood picks up oxygen and releases carbon dioxide. This is a vital part of the overall circulatory system, which delivers nutrients and oxygen to the body's cells while removing waste products like carbon dioxide.

In pulmonary circulation, deoxygenated blood from the systemic circulation returns to the right atrium of the heart via the superior and inferior vena cava. The blood then moves into the right ventricle through the tricuspid valve and gets pumped into the pulmonary artery when the right ventricle contracts.

The pulmonary artery divides into smaller vessels called arterioles, which further branch into a vast network of tiny capillaries in the lungs. Here, oxygen from the alveoli diffuses into the blood, binding to hemoglobin in red blood cells, while carbon dioxide leaves the blood and is exhaled through the nose or mouth.

The now oxygenated blood collects in venules, which merge to form pulmonary veins. These veins transport the oxygen-rich blood back to the left atrium of the heart, where it enters the systemic circulation once again. This continuous cycle enables the body's cells to receive the necessary oxygen and nutrients for proper functioning while disposing of waste products.

Prolonged pregnancy, also known as post-term pregnancy, is a medical condition defined as a pregnancy that continues beyond 42 weeks (294 days) of gestation from the first day of the last menstrual period. It is important to note that this definition is based on the estimated date of delivery and not the actual conception date. Prolonged pregnancies are associated with increased risks for both the mother and the fetus, including stillbirth, meconium aspiration, fetal distress, and difficulty during labor and delivery. Therefore, healthcare providers closely monitor pregnant women who reach 41 weeks of gestation to ensure timely delivery if necessary.

  • Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. (nih.gov)
  • Persistent fetal circulation is a condition caused by a failure in the systemic circulation and pulmonary circulation to convert from the antenatal circulation pattern to the "normal" pattern. (wikipedia.org)
  • Autologous pbpc use has increased because aspirin irreversibly inhibits adenosine deaminase, an enzyme highly expressed in milligrams, whereas the dual advantage o ewer drugdrug interactions, it should be warned about the arteries in the upper brainstem, one o the resulting increase in systemic vascular resistance "persistent fetal circulation. (gec-group.com)
  • Consequently, a mixture of oxygenated and deoxygenated blood enters systemic, pulmonary, and coronary circulations. (msdmanuals.com)
  • The prenatal diagnosis of CHD is crucial to improve patient outcomes, especially for fetuses with conditions such as transposition of the great arteries and duct-dependent systemic or pulmonary circulation. (e-ultrasonography.org)
  • This common trunk carries blood from the heart to the body, lungs and the heart itself - that is, the common trunk gives rise to the systemic, pulmonary and coronary circulation. (cdc.gov)
  • Smith A, Molloy E, Miletin J, Curley A, Balfe J, Orla F, EL-Khuffash A, 'Longitudinal assessment of cardiac function in infants with Down's syndrome using novel echocardiography techniques-project protocol. (tcd.ie)
  • Under these circumstances, advances in prenatal ultrasound cardiac screening, and fetal echocardiography are important tools for the early detection of most CHD cases. (e-ultrasonography.org)
  • Common truncus can be diagnosed prenatally by fetal echocardiography, although in some cases it might be difficult to conclusively distinguish from other conditions (e.g. pulmonary atresia with ventricular septal defect or aortic atresia with ventricular septal defect). (cdc.gov)
  • We also use the presence of polyhydramnios (too much amniotic fluid) and elevated fetal cardiac output on fetal echocardiography. (connecticutchildrens.org)
  • The failure of the circulatory system of the newborn to adapt to these changes by lowering PVR leads to persistent fetal circulation. (wikipedia.org)
  • Because of this, the condition is also widely known as persistent pulmonary hypertension of the newborn (PPHN). (wikipedia.org)
  • Objectives: Evaluate the short-term effects of IV epoprostenol in neonates with persistent pulmonary hypertension (PPHN) of the newborn. (elsevierpure.com)
  • Alveolar capillary dysplasia, although rare, is a universally fatal form of persistent pulmonary hypertension of the newborn. (ox.ac.uk)
  • Persistent pulmonary hypertension of the newborn (PPHN) is defined as the failure of the normal circulatory transition that occurs after birth. (medscape.com)
  • Idiopathic persistent pulmonary hypertension of the newborn can present without signs of acute perinatal distress. (medscape.com)
  • In contrast to adult primary pulmonary hypertension, the newborn syndrome is not defined by a specific pressure of the pulmonary circulation. (medscape.com)
  • In a recent study published in the New England Journal of Medicine, women who took antidepressants in the third trimester delivered babies who were six times more likely to have persistent pulmonary hypertension of the newborn (PPHN) or developing a lung disorder, primary pulmonary hypertension (PPH) than babies not exposed to SSRIs. (toxicdoselaw.com)
  • This study focused on newborn babies with persistent pulmonary hypertension (PPHN), which is a serious and life-threatening lung condition that occurs soon after birth of the newborn. (toxicdoselaw.com)
  • During November 2011, an enzootic outbreak causing fetal death or neurologic signs in newborn lambs, kids, and calves emerged throughout several countries in Europe. (cdc.gov)
  • We use of ratio of the estimated fetal weight of the acardiac twin to the estimated fetal weight of the pump twin to identify pregnancies at risk. (connecticutchildrens.org)
  • The genetic changes associated with this condition usually occur during the formation of reproductive cells (eggs and sperm) or in early fetal development. (medlineplus.gov)
  • The ovum from which the fetus is formed develops during the early fetal life of the mother. (cdc.gov)
  • Examples of cases with newborns who with sustained fetal circulation are pulmonary hypoplasia and genetic abnormalities. (wikipedia.org)
  • Recent studies have been linked SSRI Antidepressants to birth defects and other health problems in babies including persistent pulmonary hypertension in newborns (PPHN) or developing a lung disorder, primary pulmonary hypertension (PPH). (toxicdoselaw.com)
  • Newborns who breathe in meconium, a thick, sticky substance normally found in the fetal bowel, also are at risk. (britannica.com)
  • Both syndromes were associated with the genome of a new Shamonda/Sathuperi-like orthobunyavirus named Schmallenberg virus (SBV) in the blood (adults) or central nervous system (newborns) ( 1 , 2 ). (cdc.gov)
  • Newborns with persistent pulmonary hypertension as a symptom of fetal illness or malformation or after a relapse into fetal circulation without obvious reason. (gu.se)
  • Apneas represent another important group of respiratory/ventilation dysfunctions in newborns (apart from perinatal asphyxia and respiratory distress syndrome). (infantools.com)
  • The virus replicates itself in the placenta and infects the foetus, causing the constellation of abnormalities denoted by the name of Congenital Rubella Syndrome. (resistbiden.org)
  • It is a syndrome characterized by marked pulmonary hypertension that causes hypoxemia secondary to right-to-left shunting of blood at the foramen ovale and ductus arteriosus. (medscape.com)
  • Why do two key fetal blood vessels, the ductus arteriosus and the pulmonary arteries, have opposite responses to the rise in blood oxygen that occurs with the newborn's first breath? (phacanada.ca)
  • Auscultation of the chest showed normal heart sounds with a slight early systolic murmur, maximal at the upper left sternal border, attributed to a persistent ductus arteriosus as evidenced by cardiac ultrasonography. (bmj.com)
  • 1999]. Few studies have been conducted of altered sex ratio with maternal exposure to persistent pollutants. (cdc.gov)
  • HDlive enables reconstruction of the fetal heart structures in realistic views starting from cardiac ultrasound views. (e-ultrasonography.org)
  • Advanced imaging and Doppler modalities, such as three-dimensional (3D) and four-dimensional (4D) ultrasonography, have enhanced the accuracy of prenatal CHD detection by providing high-quality images that enable a detailed analysis of fetal cardiac anatomy and function [ 5 , 6 ]. (e-ultrasonography.org)
  • Starting from the acquisition of a four-chamber view of the fetal heart, cardiac volumes can be displayed in both multiplanar and rendering modes, in a static view or in movement (4D), which offers potential advantages over two-dimensional (2D) ultrasonography as it is less dependent on the experience of the operator to obtain high-quality images, requiring less time for the fetal cardiac examination [ 7 , 8 ]. (e-ultrasonography.org)
  • The development of heart failure is seen by progressively higher cardiac output on fetal echocardiogram, finally with the development of hydrops (abnormal fluid collections in the chest and abdomen) and swelling of the skin, indicating severe heart failure. (connecticutchildrens.org)
  • DiGeorge Syndrome DiGeorge syndrome is thymic and parathyroid hypoplasia or aplasia leading to T-cell immunodeficiency and hypoparathyroidism. (msdmanuals.com)
  • Persistent truncus arteriosus occurs when, during fetal development, the primitive truncus does not divide into the pulmonary artery and aorta, resulting in a single, large, arterial trunk that overlies a large, malalignment type ventricular septal defect. (msdmanuals.com)
  • Other terms for the condition are (persistent) truncus arteriosus. (cdc.gov)
  • PPH is not a common condition, but it occurs more often when lung disease such as respiratory distress syndrome (hyaline membrane disease) or pneumonia is present, or when the lungs are under-developed. (britannica.com)
  • Persistent fetal circulation in neonates can be reversible or irreversible depending on the classified etiology listed above. (wikipedia.org)
  • The International Society of Ultrasound and Gynecology (ISUOG) recommendation of incorporating visualization of the outflow tract views as well as the four-chamber view into the routine prenatal ultrasound assessment of the fetal heart is evidence-based and has been contributed to improve the prenatal CHD detection rate [ 3 , 4 ]. (e-ultrasonography.org)
  • A 3 week old infant presented with persistent hypoxaemia and was diagnosed with pulmonary arteriovenous malformations. (bmj.com)
  • We report on a 3 week old infant who presented with persistent hypoxaemia as a result of pulmonary AVM. (bmj.com)
  • During critical periods of organogenesis (i.e., the 6-week period that follows the establishment of the placental circulation). (cdc.gov)
  • Hereditary haemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an autosomal dominant mucocutaneous and visceral vascular dysplasia, characterised by the occurrence of telangiectasia and arteriovenous malformations (AVMs). (bmj.com)
  • Exposures to hazardous substances during pregnancy can potentially affect the development of fetal organ systems. (cdc.gov)
  • Once the ratio of the acardiac-to-pump twin weight exceeds 0.7, it identifies a pregnancy with a 90% chance of adverse pregnancy outcome without fetal intervention. (connecticutchildrens.org)
  • Synthesis:Estriol is only produced in significant amounts during pregnancy as it is made by the placenta from 16-Hydroxydehydroepiandrosterone sulfate , an androgen steroid made in the fetal liver and adrenal glands.The human. (absoluteastronomy.com)
  • For a great explanation about the fetoplacental circulation the following 5 minute video link is extremely useful in assisting ultrasound practitioners understand the direction of blood flow. (ultrasoundpaedia.com)
  • In this scenario, ultrasound operators can freely select a better light source position to enhance the anatomical details of the fetal heart. (e-ultrasonography.org)
  • There have been a number of fetal interventions described to treat TRAP sequence, but it is clear that the best outcomes are achieved with ultrasound-guided intra fetal radiofrequency ablation. (connecticutchildrens.org)
  • When PPH occurs without any of these risk factors, it often is called persistent fetal circulation. (britannica.com)
  • In severe respiratory distress syndrome in preterm lambs, rescue treatment with alveolar recruitment strategies, HFOV and PLV, resulted in improved oxygenation. (gu.se)
  • Hyperinsulinism (HI) is the most common cause of severe, persistent hypoglycemia in infants and children. (medscape.com)
  • In the fetal circulatory system , most blood pumped out of the heart is diverted away from the lungs through two passages, one connecting the two atria (the upper chambers of the heart) and one connecting the pulmonary artery-which normally delivers blood to the lungs-with the aorta. (britannica.com)
  • The circulatory system adapts to this by closing off the fetal bypass circulation (which is called a shunt). (britannica.com)
  • Causes include hypoxia, meconium aspiration, and respiratory distress syndrome. (wikipedia.org)
  • A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation that is commonly seen in infants. (sdsu.edu)
  • The middle line represents an iop range that will di erentiate primary hypokalemic periodic paralysis hyperpp andersen awil syndrome a ter he was prescribed azithromycin for a fib, decrease dose mg kg every hours in premature infants or infants who fail pharmacologic interventions. (gec-group.com)
  • Infants with DiGeorge syndrome have low-set ears, midline facial. (msdmanuals.com)
  • A gradient of 10% or more in oxygenation saturation between simultaneous preductal and postductal arterial blood gas values in absence of structural heart disease documents persistent fetal circulation. (wikipedia.org)
  • Common truncus can occur with genetic syndromes such as deletion 22q11, in which many external (e.g. cleft palate) as well as internal anomalies have been described. (cdc.gov)
  • The causes of persistent HI are largely genetic. (medscape.com)
  • Several syndromic genetic forms of HI have also been identified (eg, Beckwith-Wiedemann, Kabuki, and Turner syndromes). (medscape.com)
  • Dominant hemisphere involvement result in an associated global aphasia where as non-dominant hemispheric infarct is associated with a neglect syndrome.The major clinical difference between a proximal and distal MCA stem occlusion is that with a proximal lesion the leg is plegic as well. (neuroradiologycases.com)
  • All the COVID vaccines employ the use of aborted fetal tissue whether in development, production or testing. (resistbiden.org)
  • Schneider's article equates the use of aborted fetal cell lines in vaccine development to the 'testing' applied to his list of often-prescribed and common OTC medications. (resistbiden.org)
  • Of course, aborted fetal cell lines were in the distant future, rendering their use in the development of aspirin an impossibility. (resistbiden.org)
  • This causes a significant decrease in oxygen concentration, which clinically manifests as insufficient blood flow to the lower body, while there is adequate circulation to the head and right side of the body. (wikipedia.org)
  • If the infant's pulmonary blood vessels constrict-which could happen for any of several reasons-the resulting elevated blood pressure will keep the fetal passages open. (britannica.com)
  • Foetal blood returns to the placenta from the iliac arteries into the umbilical arteries. (ultrasoundpaedia.com)
  • The posterior cerebral circulation (or simply, posterior circulation ) is the blood supply to the posterior portion of the brain, including the occipital lobes , cerebellum and brainstem . (radiopaedia.org)
  • These technologies provide fetal heart surface patterns by using a fixed virtual light source that propagates into the tissues, permitting a detailed reconstruction of the heart structures. (e-ultrasonography.org)
  • This is because the grandmother's exposures may have affected the mother's developing ova during the mother's fetal life. (cdc.gov)
  • During summer and fall of 2011, a nonspecific febrile syndrome among adult dairy cows in northwestern Europe was reported. (cdc.gov)
  • Do all TRAP sequence cases require fetal intervention? (connecticutchildrens.org)
  • While some centers have considered the presence of TRAP sequence an indication for fetal intervention, it is not necessary in all cases. (connecticutchildrens.org)
  • There remain approximately 50% of diazoxide-responsive cases and 10% of diazoxide-unresponsive cases of persistent HI with unknown etiology, suggesting that additional genes may be identified in the pathogenesis of HI. (medscape.com)
  • We report 3 cases of unusual and persistent hyperpigmentation following nonpermanent henna tattoo, which alerted us to identify an additional side effect. (who.int)

No images available that match "persistent fetal circulation syndrome"